Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design

Author： Shurtleff Amy C   Nguyen Tam L   Kingery David A   Bavari Sina  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.10, 2012-10, pp. : 935-954

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New in silico and conventional in vitro approaches to advance HIV drug discovery and design

By Maga Giovanni   Veljkovic Nevena   Crespan Emmanuele   Spadari Silvio   Prljic Jelena   Perovic Vladimir   Glisic Sanja   Veljkovic Veljko  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 83-92

Informa Healthcare

Access to resources Recommend Favorite

In silico fragment-based drug design

By Konteatis Zenon D  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1047-1065

Informa Healthcare

Access to resources Recommend Favorite

High-throughput and in silico screenings in drug discovery

By Phatak Sharangdhar S   Stephan Clifford C   Cavasotto Claudio N  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 947-959

Informa Healthcare

Access to resources Recommend Favorite

Design and in silico screening of inhibitors of the cholera toxin

By Zhang Guangtao  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 923-938

Informa Healthcare

Access to resources Recommend Favorite

In silico analysis of antifungal peptides

By Soltani Saeed   Keymanesh Keykhosrow   Sardari Soroush  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 837-847

Informa Healthcare

Access to resources Recommend Favorite